JPM vs TMO: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
JPMorgan Chase & Co. · Financial Services
$350.13
+26.9% upside to fair value
Med Conviction
Grade A-
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
TMO |
| Current Price |
$350.13 |
$658.32 |
| Fair Value Estimate |
$444.48 |
$863.34 |
| Upside to Fair Value |
+26.9%
|
+31.1%
|
| Market Cap |
$938.2B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.0x
|
25.9x
|
| Price / Sales |
3.1x
|
5.3x
|
| Price / FCF |
—
|
33.4x
|
| Revenue Growth YoY |
+17.9%
|
+10.5%
|
| Gross Margin |
62.6%
|
40.4%
|
| Operating Margin |
28.2%
|
17.7%
|
| Return on Equity |
17.8%
|
13.4%
|
| Dividend Yield |
1.71% |
0.28% |
| FCF Yield |
—
|
3.0%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
JPMorgan Chase is a diversified global bank spanning consumer banking, cards, payments, commercial banking, investment banking, markets, treasury services, and asset and wealth management, with an unusually high-quality franchise supported by funding scale, distribution, leading market positions and cross-selling across 86.6 million U.S. consumers and more than 90% of Fortune 500 companies. Busin…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
JPM |
TMO |
| Zone Low |
$333.36 |
$647.50 |
| Zone High |
$377.81 |
$733.84 |
| In Buy Zone? |
Yes
|
Yes
|